Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUC.L Regulatory News (NUC)

  • There is currently no data for NUC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of long term incentive awards

20 May 2020 15:44

RNS Number : 5261N
Nucleus Financial Group PLC
20 May 2020
 

20 May 2020

Nucleus Financial Group plc

("Nucleus" or the "Company")

Grant of long term incentive awards to Executive Directors and other Persons Discharging Managerial Responsibility ("PDMRs")

Director/ PDMR shareholding

 

Nucleus announces that, on 19 May 2020, it granted long term incentive awards in the form of nil-cost options (the "Awards") over its ordinary shares of 0.1 pence each ("Shares") to the Executive Directors and other PDMRs set out below under the terms of its Long Term Incentive Plan (the "LTIP") that was established at the time of its original admission to AIM.

PDMR

Role

No. of shares over which awards were granted

David Ferguson

Chief Executive Officer

311,715

Stuart Geard

Chief Finance Officer

233,000

Barry Neilson

Chief Customer Officer

127,908

Andrew Smith

Chief Technology Officer

139,172

Kirsty Lynagh

Chief People Officer

103,029

The vesting of each of the Awards is subject to the satisfaction of performance conditions that will be measured over prescribed three-year periods and which relate to the achievement of targets applicable to earnings per share, net-inflow of assets under administration and total shareholder return. Vesting will also normally be dependent on the continued employment of the participant within the Company's group.

The following notifications are intended to satisfy the Company's obligations under Article 19(3) of EU Regulation No 596/2014 (the Market Abuse Regulation).

 

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. David Ferguson

2. Stuart Geard

3. Barry Neilson

4. Andrew Smith

5. Kirsty Lynagh

 

2.

Reason for the notification

a)

Position / status

1. Chief Executive Officer

2. Chief Finance Officer

3. Chief Customer Officer

4. Chief Technology Officer

5. Chief People Officer

 

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Nucleus Financial Group plc

b)

LEI

213800MAIAI3M7LM5950

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

c)

Description of the financial instrument

Ordinary shares of 0.1p each

 

ISIN: GB00BG226J60

d)

Nature of the transaction

Grant of awards (in the form of nil-cost options) over Shares pursuant to the Company's Long Term Incentive Plan

e)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

 

1. 311,715

2. 233,000

3. 127,908

4. 139,172

5. 103,029

 

f)

Aggregated information

 

Aggregated volume

 

Price

1. N/A single transaction

2. N/A single transaction

3. N/A single transaction

4. N/A single transaction

5. N/A single transaction

 

g)

Date of the transaction

19 May 2020

 

h)

Place of the transaction

Outside a trading venue

    

 

For further information please contact:

 

Nucleus

Stuart Geard, Chief Financial Officer Tel: +44 (0)13 1226 9800

Shore Capital (Nominated Adviser and Broker)

Hugh Morgan Tel: +44 (0)20 7408 4090

Edward Mansfield

Daniel Bush 

Camarco (Media enquiries)

Jennifer Renwick Tel: +44 (0)20 3757 4994

Jake Thomas

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHZBLFLBELZBBL
Date   Source Headline
21st Sep 20217:30 amRNSSuspension - Nucleus Financial Group plc
7th Sep 20217:00 amRNSStrategic Update and Directorate Change
23rd Aug 202112:28 pmRNSNotice of proposed cancellation of trading on AIM
10th Aug 20213:19 pmRNSForm 8.3 - Nucleus Financial Group PLC
6th Aug 20215:30 pmRNSNucleus Financial Group
6th Aug 20212:28 pmRNSDirector/PDMR Shareholding
6th Aug 20217:30 amRNSDirector changes
6th Aug 20217:00 amRNSOffer wholly unconditional
16th Jul 20217:00 amRNSQ2 2021 AUA update
18th Jun 20218:50 amRNSDirector/PDMR Shareholding
10th Jun 20219:28 amRNSForm 8.3 - Nucleus Financial Group Plc
27th May 202110:08 amRNSResult of AGM
25th May 20212:55 pmRNSUpdate on Offer Timetable and Level of Acceptances
17th May 20215:28 pmRNSDirector/PDMR Shareholding
5th May 20217:00 amRNSOffer unconditional as to acceptances
27th Apr 202110:07 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
23rd Apr 202110:14 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
21st Apr 20218:30 amRNSForm 8.3 - Nucleus Financial Group PLC
20th Apr 20218:57 amRNSForm 8.3 - Nucleus Financial Group PLC
14th Apr 20212:51 pmRNSDirector/PDMR Shareholding
14th Apr 20219:45 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
13th Apr 20212:51 pmRNSForm 8 (DD) - Nucleus Financial Group plc
13th Apr 20212:16 pmRNSDirector/PDMR Shareholding
13th Apr 202112:35 pmRNSPublication and posting of Offer Document
13th Apr 20219:48 amRNSForm 8.3 - [NUCLEUS FINANCIAL GROUP PLC]
13th Apr 20219:45 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
13th Apr 20217:00 amRNSQ1 2021 AUA update
9th Apr 20219:17 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
9th Apr 20218:51 amRNSForm 8.3 - NUCLEUS FINANCIAL GROUP PLC
9th Apr 20217:00 amRNSOffer Document – change of publication date
7th Apr 20213:15 pmRNSNotice of AGM - amendment
7th Apr 20218:55 amRNSForm 8.3 - NUCLEUS FINANCIAL GROUP PLC
7th Apr 20217:00 amRNSNotice of AGM
1st Apr 202110:34 amRNSForm 8.3 - [NUCLEUS FINANCIAL GROUP PLC]
31st Mar 202110:44 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
31st Mar 20218:55 amRNSForm 8.3 - [NUCLEUS FINANCIAL GROUP PLC]
30th Mar 202111:52 amRNSRecommended Cash Offer
29th Mar 20214:21 pmRNSDirector/PDMR Shareholding
25th Mar 20213:58 pmRNSDirector/PDMR Shareholding
25th Mar 20219:38 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
25th Mar 20218:37 amRNSForm 8.3 - Nucleus Financial Group PLC
24th Mar 20219:24 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
23rd Mar 20217:00 amRNSFinal results
19th Mar 20219:34 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
17th Mar 202112:08 pmGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
17th Mar 20218:59 amRNSForm 8.3 - NUCLEUS FINANCIAL GROUP PLC
16th Mar 20218:52 amRNSForm 8.3 - NUCLEUS FINANCIAL GROUP PLC
15th Mar 20214:45 pmRNSForm 8 (DD) - Nucleus Financial Group plc
15th Mar 20214:39 pmRNSDirector/PDMR Shareholding
15th Mar 202111:46 amRNSForm 8.3 - Nucleus Financial Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.